Project management performance measures in a regulatory environment: An initial examination

Drug Information Journal

Volumn 34, Issue 1, 2000, Pages 87-90

  Chasin, Steven H ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE   (United States)

Author keywords

Food and Drug Administration; Government Performance and Results Act; GPRA; Performance measurement; Results Act

Indexed keywords

ARTICLE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; LAW; MANAGEMENT; PERFORMANCE; PRIORITY JOURNAL; RESEARCH;

EID: 0034047758     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400111     Document Type: Article

References (3)

1. DiMasi J, et al. Initiatives to speed new drug development and regulatory review: The impact of FDA-sponsor conferences. Drug Inf J. 1997;31(3):771-788.
2. FDA Modernization Act. PL 105-115.
3. Case R. The Structure of High-Performing Project Management Organizations. Drug Inf J. 1998;32(3): 577-607.